F16.21 – Hallucinogen dependence, in remission
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
Applicable To
Other hallucinogen use disorder, moderate, in early remission
Other hallucinogen use disorder, moderate, in sustained remission
Other hallucinogen use disorder, severe, in early remission
Other hallucinogen use disorder, severe, in sustained remission
Phencyclidine use disorder, moderate, in early remission
Phencyclidine use disorder, moderate, in sustained remission
Phencyclidine use disorder, severe, in early remission
Phencyclidine use disorder, severe, in sustained remission
GEM Conversion to ICD-9 CM
Fs: 00000
–
Hallucinogen dependence, in remission
Back Reference of Diagnostic Codes
Dependence
(on) (syndrome)
F19.20
Disorder
(of)
See also Disease
hallucinogen use
in remission
(early) (sustained)
F16.21
phencyclidine use
in remission
(early) (sustained)
F16.21
Sibling Codes
Parent Sibling Codes
View in Tabular
| Code | Title |
|---|---|
| F01-F99 | Mental, Behavioral and Neurodevelopmental disorders (F01-F99) |
| F10-F19 | Mental and behavioral disorders due to psychoactive substance use (F10-F19) |
| F16 | Hallucinogen related disorders |
| F16.2 | Hallucinogen dependence |
| F16.21 |
Hallucinogen dependence, in remission
Applicable to
Other hallucinogen use disorder, moderate, in early remission
Other hallucinogen use disorder, moderate, in sustained remission
Other hallucinogen use disorder, severe, in early remission
Other hallucinogen use disorder, severe, in sustained remission
Phencyclidine use disorder, moderate, in early remission
Phencyclidine use disorder, moderate, in sustained remission
Phencyclidine use disorder, severe, in early remission
Phencyclidine use disorder, severe, in sustained remission
|